Protalix BioTherapeutics Inc (PLX) is traded on Tel Aviv Stock Exchange in Israel. It is located in 2 Snunit Street and employs 232 people. The company currently falls under 'Small-Cap' category with current market capitalization of 336.8 M. Protalix BioTherapeutics Inc has 133.84 M outstanding shares.
PROTALIX BIOTCS has accumulated about 33.48 M in cash with (34.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Check Protalix BioTherapeutics Probability Of Bankruptcy